Skip to main content
. 2024 Jan 23;331(4):302–317. doi: 10.1001/jama.2023.26491

Figure 2. Overall and Prostate Cancer–Specific Survival in Patients With Localized Prostate Cancer.

Figure 2.

Overall and prostate cancer–specific survival probabilities were calculated using the Kaplan-Meier method for men with favorable-prognosis and unfavorable-prognosis prostate cancer through 10 years. Participants were censored at the date of the last registry follow-up. The median time of observation for the favorable-prognosis group was 9.5 years (IQR, 9.2-9.8), and for the unfavorable-prognosis group was 9.4 years (IQR, 9.0-9.8).